Dabigatran Etexilate Mesylate capsule- Gels| third party manufacturing

Therapeutic Indication

Prevention of stroke and systemic embolism

Atrial fibrillation

Deep vein thrombosis

Pulmonary embolism

+91 85919 78885

Dabigatran Etexilate Mesylate

Capsule

Dabigatran Etexilate Mesylate capsules contain the active substance dabigatran etexilate, which belongs to a class of medicines called direct oral anticoagulants (DOACs). It helps prevent blood clots by inhibiting thrombin, an enzyme essential for clot formation.

Speciality	Cardiology / Hematology
Tags	Anticoagulant \| Blood Thinner \| DVT \| Stroke Prevention \| DOAC
Strength	150 mg 110 mg
Packing Size	10 x 1 x 10 Alu Alu

Check all Tablets Range

Click to know More

Mechanism

Dabigatran is a direct thrombin (Factor IIa) inhibitor. It prevents the conversion of fibrinogen to fibrin, thereby reducing clot formation and preventing thromboembolic events.

Side Effects

Gastrointestinal discomfort
Nausea
Bleeding

Dosage

As directed by the Physician.

Contraindication

Mechanical heart valves
Hypersensitivity to Dabigatran
Active bleeding
Severe renal impairment

Interaction

P-gp inhibitor
Other anticoagulants
Antiplatelet drugs

Warning and Precautions

This has been prescribed for the patient's specific condition. It may be dangerous to any other person.

Monitor for signs of bleeding
Use cautiously in renal impairment
Do not discontinue abruptly
Store in a cool and dry place
Avoid use in patients with high bleeding risk

All product details on this website are for reference and informational purposes only and are not directed at patients or consumers.
As a contract manufacturer, DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all liability arising from reliance on this information.
Please consult a healthcare professional before using any medicinal product.